Tirzepatide, the active ingredient behind the popular weight loss drug Zepbound and the diabetes drug Mounjaro, has more ...

An outbreak of diptheria in the Kimberley. Lower risk of cancer for boys who get a HPV vaccine. Negotiations stall on adding Mounjaro to the PBS for people with type 2 diabetes. References Outbreak of ...

Ive been on a GLP-1 for over two years, and its completely changed my skincare regimen. While its brought some of the most ...

GLP-1 receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide agonists are not likely to decrease the ...

As of April 2026, more than 40 million GLP-1 receptor agonist prescriptions are dispensed annually in the United States alone, driven by blockbuster drugs like Ozempic (semaglutide) and Mounjaro ...

Side effects like nausea, vomiting, diarrhea and constipation are common soon after starting GLP-1s or increasing the drug’s dosage. A nutrient-dense diet and regular exercise a ...

Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need ...

In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.

GLP-1 shots and pills both help regulate appetite and blood sugar. Learn the differences in effectiveness, cost, and who ...

Online ads and videos falsely tied public figures to a supposed gelatin-based weight loss method and related products such as Gelatide.

Earnings call Roche delivered robust Q1 2026 results with group sales up 6% at constant exchange rates (CER), driven by Pharma (+7%) and Diagnostics (+3%, +5% ex-China). Management reaffirmed ...

Wellness and longevity influencers are pushing a compound called NAD+. There's scientific interest in its potential, but ...